Ottobock
Private Company
Total funding raised: $15M
Overview
Ottobock is a century-old, privately-held leader in the orthotics and prosthetics (O&P) sector, with a strong global presence and a mission centered on human empowerment through mobility. The company leverages deep expertise in biomechanics, materials science, and microprocessor technology to create innovative, patient-specific solutions, from the flagship Genium and C-Leg prosthetic knees to the C-Brace orthosis and workplace exoskeletons. It operates a B2B2C model, supporting a global network of certified clinicians and technicians while engaging directly with end-users through community events, ambassador programs, and educational resources. Ottobock's financial stability is underpinned by its long-established commercial operations, diverse product lines, and recurring revenue from components and services.
Technology Platform
Integrated platform combining advanced biomechanics, microprocessor control systems, sensor technology, myoelectric signal interpretation, and material science for prosthetic, orthotic, and exoskeleton solutions.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Ottobock competes with other large O&P companies like Össur (Iceland) and Fillauer (US), as well as specialized robotics firms like Ekso Bionics. In exoskeletons, competitors include Sarcos Robotics and Japanese firms like Cyberdyne. Its main competitive advantages are its century-old brand, unparalleled clinical network, deep biomechanical expertise, and full vertical integration from R&D to patient support.